drugset / Trial / NCT00925106
Pharmacokinetics Of Celecoxib Test Formulations
RandomizedCrossoverOpen-labelBasic science
Summary
The pharmacokinetics of new formulations of celecoxib are being evaluated. They are expected to provide more favorable bioavailability characteristics than the present commercial formulation.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 150 mg | — |
| Comparator | Celecoxib | Other / unclassified | 200 mg | — |
Indications
No indication recorded.